VR

Victor Rusu

Principal at Apple Tree Partners

Greater Boston

Investor
VC

Invests in

Stages:

Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Genome editing
Cell Biology
Functional Genomics
Molecular Biology
Biochemistry
Quantitative analysis of large biological datasets
Bioinformatics
R
Python
Microsoft Excel
Statistics
Ordinary Differential Equations
Partial Differential Equations
Numerical Analysis
NGS sequencing
NGS data analysis

Education

Lists including Victor

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

AT
Apple Tree Partners

2019

  • Principal

    2019

C
Citi

2018 - 2019

  • Senior Biotechnology Associate at Citi

    2018 - 2019

JT
Jnana Therapeutics

2017 - 2018

  • Senior Scientist

    2017 - 2018

BI
Broad Institute

2012 - 2017

  • PhD Graduate Student

    2012 - 2017

    - Identified molecular mechanisms through which mutations in a previously uncharacterized gene, SLC16A11, increase type 2 diabetes (T2D) risk. These mutations are among the largest known T2D risk factors. - Characterized function of SLC16A11 and impact of T2D-associated mutations using unbiased methods: metabolomics, RNA-sequencing, proteomics, and ChIP-sequencing. - Used targeted biochemical assays to demonstrate the impact of T2D-associated coding mutations on SLC16A11 binding to a chaperone protein and the resulting effects on cellular localization. - Used gene expression studies, allelic imbalance assays, and reporters to investigate impact of T2D-associated noncoding mutations on SLC16A11 gene regulation. - Performed functional experiments in primary human hepatocytes investing role of SLC16A11 in metabolism.